ASX:OILHealth Care Equipment & ServicesHealth Care Equipment
Optiscan Imaging Ltd
$0.145
Day Range
$0.145 – $0.145
52 Week Range
$0.080 – $0.200
Volume
0.00
Avg Volume (10D)
178.62K
Price Chart
OHLC · volume · moving averages
$0.145+$0.060 (+70.59%)over 6M
Hi$0.200Lo$0.080Avg Vol230.2K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.145
Previous Close
$0.145
Day High
$0.145
Day Low
$0.145
52 Week High
$0.200
52 Week Low
$0.080
Valuation
Fundamental multiples
Market Cap
0.00
Shares Outstanding
0.00
Price to Book
8.27
Trading Activity
Volume & order book
Volume
0.00
Value Traded
0.00
Bid
$0.145 × 69,989
Ask
$0.160 × 15,000
Performance
Returns across timeframes
1 Day
-3.23%
5 Day
-9.09%
13 Week
11.11%
52 Week
42.86%
YTD
50.00%
Technical Indicators
Momentum & moving averages
RSI (14)
41.21
50-Day SMA
$0.155
200-Day SMA
$0.116
— From the desk
Latest News
Biotechnology
Optiscan Launches US Study of InVue and InForm Imaging Devices for Head and Neck Cancer Surgeries
Optiscan kicks off US Mayo Clinic study of 35-patient InVue/InForm for head and neck cancer; real-time intraoperative imaging aims to back FDA submissions.
Biotechnology
Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions.
Biotechnology
Optiscan Imaging Launches First Clinical Device into US Veterinary Market
Optiscan debuts InSpecta as its first US commercial clinical imaging device after FDA CVM submission, unlocking US sales in a $15.9B market.
Biotechnology
Optiscan Submits FDA Dossier for Inspecta Imaging Device Targeting Lucrative US Veterinary Market
Optiscan submits FDA dossier for InSpecta veterinary imaging, unlocking US$11.9B market with real-time, non-invasive imaging for pets.